- Report
- June 2024
- 200 Pages
Global
From €7252EUR$7,950USD£6,199GBP
- Report
- January 2022
- 60 Pages
Global
From €3603EUR$3,950USD£3,080GBP
Otomycosis is a fungal infection of the ear canal that is caused by a variety of fungi, including Aspergillus, Candida, and Fusarium species. It is a common condition that affects both adults and children. Treatment of otomycosis typically involves the use of antifungal drugs, such as clotrimazole, miconazole, and amphotericin B. These drugs are often used in combination with other treatments, such as topical steroids and antibiotics.
In the context of oncology drugs, otomycosis drugs are used to treat fungal infections that can occur in patients undergoing chemotherapy or radiation therapy. These drugs can help reduce the risk of infection and improve the patient's quality of life. They can also help reduce the risk of complications associated with chemotherapy and radiation therapy.
Some companies in the otomycosis drug market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies produce a variety of antifungal drugs that are used to treat otomycosis. Show Less Read more